Summary of our market study

French consumption of medical optics is expected to reach 7.3 billion euros by 2022.

The global ophthalmology market is experiencing significant growth, driven by an aging population and an increase in vision disorders and pathologies. In 2022, it is estimated to be worth $63.4 billion, with annual growth expected to reach 5.5% between 2022 and 2027.

More than two billion people worldwide could have vision problems, at least half of which could be prevented or have yet to be treated.

In France, demand for eye care services continues to rise, resulting in consumption of medical optics reaching 7.3 billion euros in 2022.

Technological advances continue in the sector, with developments in refractive surgery and retinal prostheses.

Foreign trade in ophthalmic instruments and devices is balanced.

Evolving trends in the ophthalmology sector

As the population ages, demand for eye care is increasing, due to age-related eye diseases such as cataracts, macular degeneration (AMD), glaucoma and diabetic retinopathy.

In France, around 40-50% of the young population suffers from vision problems, but this percentage rises to around 95% in people over 65.

The number of visits varies according to geographical location in France, with regions such as the PACA region recording an average of 3.7 visits per year, and Corsica reaching an average of 4.3 visits.

The country's healthcare system covers around 70% of eye care costs.

The market is facing an expected 20% reduction in the number of practicing ophthalmologists by 2030. Over 50% of current practitioners are over 55.

The average waiting time for an appointment with an ophthalmologist in France is 80 days.

The French government has implemented healthcare reforms such as "ma santé 2022" and "100% Santé", which aim to transform the healthcare system and decentralize tasks to ease the workload of specialists.

Legislation has introduced the possibility of delegating certain ophthalmological tasks to orthoptists to relieve ophthalmologists.

players in the ophthalmology market

Manufacturers of ophthalmic equipment :

  • Nidek: renowned for manufacturing ophthalmic equipment
  • Karl Zeiss Meditec: offers a range of ophthalmic products, including diagnostic imaging systems, laser treatment systems and surgical instruments.
  • US Ophthalmic: A key global player, US Ophthalmic supplies a wide range of ophthalmic equipment.
  • OPKO Health: Specializing in diagnostics and pharmaceuticals.

Hospitals with specialized ophthalmology units:

  • Adolphe de Rothschild Foundation Hospital
  • Quinze-Vingts Hospital
Get all the information you need
to understand this market

Detailed content of our market study

Inforamtion

  • Number of pages : ~ 40 pages
  • Format : Digital and PDF versions
  • Last update :
Update Details

Summary and extracts

1 Market overview

1.1 Definition and scope of study

Ophthalmology is a branch of medicine concerned with the study of the eye and its components from an anatomical, physiological and pathological point of view.

In France, like all medical disciplines, ophthalmology is a highly regulated profession. The main challenge facing the profession is the ageing of its specialists, whose numbers could fall by 20% by 2030. In 2022, there will be 5,794 practicing ophthalmologists in France. At the same time, the French population's need for ophthalmic care is increasing as a result of an aging population and a lifestyle conducive to the development of vision disorders (myopia, etc.).

Specialists already working with opticians are being forced to delegate some of their tasks to orthoptists, who are becoming major players in the sector. This diversification will not be enough to meet the current and future needs of the French.

However, the sector remains attractive to manufacturers of ophthalmic devices and instruments, as the French government continues to subsidize innovations that improve treatment of chronic diseases (AMD, etc.), while trying to limit the cost of treatment.this is reflected in the development of telemedicine, particularly for ophthalmologists, for whom appointment times are the longest of all specialists.

List of charts presented in this market study

  • Number of visually impaired people
  • Evolution of the number of people with visual impairment
  • Expanding the market for ophthalmic devices and instruments
  • Medical optics consumption
  • Structure of optical spending
Show more Hide

All our studies are available online in PDF format

Take a look at an example of our research on another market!

Do you have a question about this study?   +44 238 097 0676

Latest news

Théa laboratory expands to La Rochelle - 25/07/2023
  • The Théa laboratory is building a new plant to produce ophthalmic cataract inserts.
  • The plant will meet a 20% to 30% increase in demand.
  • Sales of the ophthalmic insert are increasing, as it is used in around 60% of cataract operations.
  • The Théa laboratory has been present in the United States for three years, achieving sales of $40 million thanks to the purchase of a Swiss company. Between 2021 and 2022, Théa's sales in the U.S. have increased by 140 million euros.
  • Théa has 35 subsidiaries and offices in Europe, North and South America, North Africa and the Middle East, employing over 1,600 people.
  • Théa products are available in 75 countries.
  • In 2022, Théa recorded sales of 865 million euros.
  • Théa's sales forecast for this year is 920 million euros.
Zeiss invests 33 million euros in the extension of its Périgny plant - 03/02/2023
  • 33 million euro investment to extend Zeiss Périgny plant
  • 14,000 m2 building under construction
  • First extension in 2020: 8 million euros
  • 2,000 m2 of office space in the new building
  • Extension will create over 300 jobs
  • Work to start in January 2023
  • Handover scheduled for January 2025

Companies quoted in this study

This study contains a complete overview of the companies in the market, with the latest figures and news for each company. :

Nidek France
US Ophthalmic
OPKO Health
Centre Ophtalmologique Saint Paul
Carl Zeiss Group
Unither Groupe
Hôpital des Quinze-Vingts
Hôpital fondation Adolphe de Rothschild
Horus Pharma
Thea Laboratoires groupe
Carl Zeiss Méditec
CLSO

Choosing this study means :

Access to more than 35 hours of work

Our studies are the result of over 35 hours of research and analysis. Using our studies allows you to devote more time and added value to your projects.

Benefit from 6 years' experience and over 1,500 industry reports already produced

Our expertise enables us to produce comprehensive studies in all sectors, including niche and emerging markets.

Our know-how and methodology enable us to produce reports that offer unique value for money.

Access to several thousand articles and paid-for data

Businesscoot has access to all the paid economic press as well as exclusive databases to carry out its market research (over 30,000 articles and private sources).

To enhance our research, our analysts also use web indicators (semrush, trends, etc.) to identify market trends and company strategies. (Consult our paying sources)

Guaranteed support after your purchase

A team dedicated to after-sales service, to guarantee you a high level of satisfaction. +44 238 097 0676

A digital format designed for our users

Not only do you have access to a PDF, but also to a digital version designed for our customers. This version gives you access to sources, data in Excel format and graphics. The content of the study can therefore be easily retrieved and adapted for your specific needs.

Our offers :

the ophthalmology market | France

99 €
  • What are the figures on the size and growth of the market?
  • What is driving the growth of the market and its evolution?
  • What is the positioning of companies in the value chain?
  • Data from several dozen databases

Pack 5 études (-15%) France

75.6 € / study
378 € instead of 445 € -15%
  • 5 études au prix de 75,6€HT par étude à choisir parmi nos 800 titres sur le catalogue France pendant 12 mois
  • Conservez -15% sur les études supplémentaires achetées
  • Choisissez le remboursement des crédits non consommés au terme des 12 mois (durée du pack)

Consultez les conditions du pack et de remboursement des crédits non consommés.

Updates

Our customer references

They have consulted our studies Discover the opinions (+500)

Malcolm Vincent
Linkedin logo

Malcolm Vincent

Astoria Finance

Gregoire de Castelnau
Linkedin logo

Gregoire de Castelnau

Stags Participations

Timothé Huignard
Linkedin logo

Timothé Huignard

PWC

Paul-Alexis Kebabtchieff
Linkedin logo

Paul-Alexis Kebabtchieff

BCG

Aymeric Granet
Linkedin logo

Aymeric Granet

Publicis Consultant

interviews & case studies All interviews and case studies (45)

La pépite Interview

BFM Business

Paul-Alexis Kebabtchieff

Boston Consulting Group

Marie Guibart

Kea Partners

Elaine, Durand

Crédit Agricole, Information & Veille

Philippe Dilasser

Initiative & Finance

Anne Baudry

Metro

Amaury Wernert

Kroll (Duff & Phelps)

Smart Leaders Interview

B-Smart

Do you have a question ?
Our team is at your disposal at   +44 238 097 0676